These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
376 related articles for article (PubMed ID: 15525275)
1. Increased extracellular dopamine concentrations and FosB/DeltaFosB expression in striatal brain areas of heterozygous GDNF knockout mice. Airavaara M; Planken A; Gäddnäs H; Piepponen TP; Saarma M; Ahtee L Eur J Neurosci; 2004 Nov; 20(9):2336-44. PubMed ID: 15525275 [TBL] [Abstract][Full Text] [Related]
2. In heterozygous GDNF knockout mice the response of striatal dopaminergic system to acute morphine is altered. Airavaara M; Mijatovic J; Vihavainen T; Piepponen TP; Saarma M; Ahtee L Synapse; 2006 May; 59(6):321-9. PubMed ID: 16437537 [TBL] [Abstract][Full Text] [Related]
3. Effects of repeated morphine on locomotion, place preference and dopamine in heterozygous glial cell line-derived neurotrophic factor knockout mice. Airavaara M; Tuomainen H; Piepponen TP; Saarma M; Ahtee L Genes Brain Behav; 2007 Apr; 6(3):287-98. PubMed ID: 16879618 [TBL] [Abstract][Full Text] [Related]
4. Catalpol attenuates MPTP induced neuronal degeneration of nigral-striatal dopaminergic pathway in mice through elevating glial cell derived neurotrophic factor in striatum. Xu G; Xiong Z; Yong Y; Wang Z; Ke Z; Xia Z; Hu Y Neuroscience; 2010 Apr; 167(1):174-84. PubMed ID: 20123001 [TBL] [Abstract][Full Text] [Related]
5. Long-term glial cell line-derived neurotrophic factor overexpression in the intact nigrostriatal system in rats leads to a decrease of dopamine and increase of tetrahydrobiopterin production. Sajadi A; Bauer M; Thöny B; Aebischer P J Neurochem; 2005 Jun; 93(6):1482-6. PubMed ID: 15935064 [TBL] [Abstract][Full Text] [Related]
6. Behavioral and neurochemical effects of intranigral administration of glial cell line-derived neurotrophic factor on aged Fischer 344 rats. Hebert MA; Gerhardt GA J Pharmacol Exp Ther; 1997 Aug; 282(2):760-8. PubMed ID: 9262339 [TBL] [Abstract][Full Text] [Related]
7. Functional effects of GDNF in normal rat striatum: presynaptic studies using in vivo electrochemistry and microdialysis. Hebert MA; Van Horne CG; Hoffer BJ; Gerhardt GA J Pharmacol Exp Ther; 1996 Dec; 279(3):1181-90. PubMed ID: 8968339 [TBL] [Abstract][Full Text] [Related]
8. Astrocyte delivery of glial cell line-derived neurotrophic factor in a mouse model of Parkinson's disease. Cunningham LA; Su C Exp Neurol; 2002 Apr; 174(2):230-42. PubMed ID: 11922664 [TBL] [Abstract][Full Text] [Related]
9. Striatal GDNF administration increases tyrosine hydroxylase phosphorylation in the rat striatum and substantia nigra. Salvatore MF; Zhang JL; Large DM; Wilson PE; Gash CR; Thomas TC; Haycock JW; Bing G; Stanford JA; Gash DM; Gerhardt GA J Neurochem; 2004 Jul; 90(1):245-54. PubMed ID: 15198683 [TBL] [Abstract][Full Text] [Related]
10. Chronic treatment with a dopamine uptake blocker changes dopamine and acetylcholine but not glutamate and GABA concentrations in prefrontal cortex, striatum and nucleus accumbens of the awake rat. Hernández LF; Segovia G; Mora F Neurochem Int; 2008 Feb; 52(3):457-69. PubMed ID: 17881090 [TBL] [Abstract][Full Text] [Related]
11. Clozapine-, but not haloperidol-, induced increases in deltaFosB-like immunoreactivity are completely blocked in the striatum of mice lacking D3 dopamine receptors. Robertson GS; Lee CJ; Sridhar K; Nakabeppu Y; Cheng M; Wang YM; Caron MG Eur J Neurosci; 2004 Dec; 20(11):3189-94. PubMed ID: 15579174 [TBL] [Abstract][Full Text] [Related]
12. The effect of GDNF on nigrostriatal dopaminergic function in response to a two-pulse K(+) stimulation. Xu K; Dluzen DE Exp Neurol; 2000 Dec; 166(2):450-7. PubMed ID: 11085910 [TBL] [Abstract][Full Text] [Related]
13. Characterization of the striatal dopaminergic neurotransmission in MEN2B mice with elevated cerebral tissue dopamine. Mijatovic J; Patrikainen O; Yavich L; Airavaara M; Ahtee L; Saarma M; Piepponen TP J Neurochem; 2008 Jun; 105(5):1716-25. PubMed ID: 18248620 [TBL] [Abstract][Full Text] [Related]
14. Marked dopaminergic cell loss subsequent to developmental, intranigral expression of glial cell line-derived neurotrophic factor. Chun HS; Yoo MS; DeGiorgio LA; Volpe BT; Peng D; Baker H; Peng C; Son JH Exp Neurol; 2002 Feb; 173(2):235-44. PubMed ID: 11822887 [TBL] [Abstract][Full Text] [Related]
15. Single administration of 1-benzyl-1,2,3,4-tetrahydroisoquinoline increases the extracellular concentration of dopamine in rat striatum. Katagiri N; Abe K; Kitabatake M; Utsunomiya I; Horiguchi Y; Hoshi K; Taguchi K Neuroscience; 2009 Jun; 160(4):820-8. PubMed ID: 19285542 [TBL] [Abstract][Full Text] [Related]
16. The effects of apomorphine and D-amphetamine on striatal c-Fos expression in Sprague-Dawley and Long Evans rats and their F1 progeny. Saint Marie RL; Neary AC; Shoemaker JM; Swerdlow NR Brain Res; 2006 Nov; 1119(1):203-14. PubMed ID: 16979142 [TBL] [Abstract][Full Text] [Related]
17. Regulation of astroglial-derived dopaminergic neurotrophic factors by interleukin-1 beta in the striatum of young and middle-aged mice. Ho A; Blum M Exp Neurol; 1997 Nov; 148(1):348-59. PubMed ID: 9398477 [TBL] [Abstract][Full Text] [Related]
18. Cocaine-induced Fos expression in rat striatum is blocked by chloral hydrate or urethane. Kreuter JD; Mattson BJ; Wang B; You ZB; Hope BT Neuroscience; 2004; 127(1):233-42. PubMed ID: 15219685 [TBL] [Abstract][Full Text] [Related]
19. GDNF applied to the MPTP-lesioned nigrostriatal system requires TGF-beta for its neuroprotective action. Schober A; Peterziel H; von Bartheld CS; Simon H; Krieglstein K; Unsicker K Neurobiol Dis; 2007 Feb; 25(2):378-91. PubMed ID: 17141511 [TBL] [Abstract][Full Text] [Related]
20. Effects of chronic nicotine administration and its withdrawal on striatal FosB/DeltaFosB and c-Fos expression in rats and mice. Marttila K; Raattamaa H; Ahtee L Neuropharmacology; 2006 Jul; 51(1):44-51. PubMed ID: 16631212 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]